Navigation Links
LifeStem International, Inc. Announces Increased Revenues, Decreased Operating Expenses
Date:5/14/2008

LAGUNA HILLS, Calif., May 14 /PRNewswire-FirstCall/ -- LifeStem International, Inc., (OTC Bulletin Board: LSTM), formerly CalbaTech, Inc., an emerging life sciences company concentrating on providing products and platforms to the research market for biotech and pharmaceutical companies and to academic institutions, as well as providing services in the collection, processing and storage of adult stem cells, today announced revenues for the first quarter of 2008 ending March 31 totaled $318,853, up from revenues of $311,970 in the same period in 2007.

The Company also announced that its gross profit increased to $195,260 in 2008 compared to $159,828 during the same period last year. "Significantly, we were able to decrease operating expenses twenty-four percent to $356,060 in the first quarter of 2008 compared to $471,922 last year," said James DeOlden, CEO. LifeSteam International announced a loss for the quarter due to adjustments for non-operating, non-cash derivates embedded in the Company's financing instrument.

"The therapeutic possibilities that may be provided by collecting and preserving healthy adult stem cells on a pre-disease basis may revolutionize the practice of medicine. The power and promise of stem cell therapies is just emerging, and the corresponding development of new clinical applications and therapies are expected to follow. LifeStem's Stem Cell Microbank(TM) Service focuses on refining existing collection processes that are gaining significant acceptance. The focus will be providing a stem cell collection process and storage service that maintains adult stem cells for future use and broadens the availability of a collection and storage service," Mr. DeOlden said. The Company's initial client collections through the Stem Cell Microbank(TM), originally scheduled for May 10, have been, at the clients' request, rescheduled for June 20.

About LifeStem International, Inc.

LifeStem International, Inc. (OTC Bulletin B
'/>"/>

SOURCE LifeStem International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures
2. JPMorgans Principal Investment Management Group to Invest in Chindex International, Inc.
3. Corium International, Inc. Announces Appointment of Phyllis Gardner, M.D. and Daniel G. Welch to Board
4. China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program
5. Chindex International, Inc. to Present at 2008 UBS Global Healthcare Services Conference
6. Cryo-Cell International, Inc. Reports Results for Fiscal 2007
7. Bio-Clean International, Inc. to Present at Bluechip Capital Investment Forum
8. MINRAD International, Inc. Announces Appointment of David T. DiGiacinto as President and Chief Operating Officer
9. VWR International, LLC Acquires Jencons (Scientific) Ltd, UK
10. Sangui BioTech International, Inc., Reports Sales Increase, Continued Losses
11. Cryo-Cell International, Inc. Reports First Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):Nanomedicine: Ending 'hit and miss' design 2Nanomedicine: Ending 'hit and miss' design 3From fruit fly wings to heart failure -- why Not(ch)? 2Physical education teaching staff play key role in making you like sport 2Magid Abou Gharbia Ph D FRSC Joins LAXAI as Scientific Advisor 13725 1Magid Abou Gharbia Ph D FRSC Joins LAXAI as Scientific Advisor 13725 2Magid Abou Gharbia Ph D FRSC Joins LAXAI as Scientific Advisor 13725 3U S Childhood Vaccine Rates Good But Could Be Better 3A CDC 55563 1U S Childhood Vaccine Rates Good But Could Be Better 3A CDC 55563 2ThromboGenics NV Announces Business Update and Half Year Results 2009 13723 1ThromboGenics NV Announces Business Update and Half Year Results 2009 13723 2ThromboGenics NV Announces Business Update and Half Year Results 2009 13723 3ThromboGenics NV Announces Business Update and Half Year Results 2009 13723 4ThromboGenics NV Announces Business Update and Half Year Results 2009 13723 5ThromboGenics NV Announces Business Update and Half Year Results 2009 13723 6ThromboGenics NV Announces Business Update and Half Year Results 2009 13723 7ThromboGenics NV Announces Business Update and Half Year Results 2009 13723 8ThromboGenics NV Announces Business Update and Half Year Results 2009 13723 9ThromboGenics NV Announces Business Update and Half Year Results 2009 13723 10ThromboGenics NV Announces Business Update and Half Year Results 2009 13723 11ThromboGenics NV Announces Business Update and Half Year Results 2009 13723 12ThromboGenics NV Announces Business Update and Half Year Results 2009 13723 13ThromboGenics NV Announces Business Update and Half Year Results 2009 13723 14ThromboGenics NV Announces Business Update and Half Year Results 2009 13723 15